Commonwealth Equity Services LLC Has $1.48 Million Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Commonwealth Equity Services LLC raised its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 7.8% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 7,984 shares of the company’s stock after acquiring an additional 575 shares during the period. Commonwealth Equity Services LLC’s holdings in Inspire Medical Systems were worth $1,480,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Wasatch Advisors LP lifted its position in shares of Inspire Medical Systems by 1.6% in the third quarter. Wasatch Advisors LP now owns 1,323,470 shares of the company’s stock worth $279,318,000 after purchasing an additional 20,481 shares in the last quarter. State Street Corp boosted its stake in shares of Inspire Medical Systems by 78.0% during the 3rd quarter. State Street Corp now owns 1,049,784 shares of the company’s stock worth $221,557,000 after buying an additional 459,990 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of Inspire Medical Systems by 5.8% in the third quarter. Janus Henderson Group PLC now owns 502,609 shares of the company’s stock valued at $106,075,000 after acquiring an additional 27,374 shares during the last quarter. Geode Capital Management LLC raised its holdings in Inspire Medical Systems by 0.7% during the third quarter. Geode Capital Management LLC now owns 483,654 shares of the company’s stock worth $102,102,000 after acquiring an additional 3,128 shares in the last quarter. Finally, TimesSquare Capital Management LLC acquired a new position in Inspire Medical Systems during the fourth quarter valued at approximately $80,419,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on INSP shares. Wells Fargo & Company lowered their price target on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 11th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a research report on Tuesday, February 11th. Stifel Nicolaus decreased their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research report on Tuesday, January 21st. Truist Financial dropped their target price on shares of Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a report on Tuesday, February 11th. Finally, KeyCorp reiterated an “overweight” rating and set a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Inspire Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $226.70.

Inspire Medical Systems Stock Down 2.5 %

Inspire Medical Systems stock opened at $156.91 on Friday. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The stock has a market cap of $4.67 billion, a P/E ratio of 90.70, a P/E/G ratio of 2.86 and a beta of 1.48. The company’s 50-day moving average price is $179.14 and its two-hundred day moving average price is $190.04.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. Equities analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Randy Ban sold 25,584 shares of the firm’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the transaction, the insider now directly owns 7,259 shares of the company’s stock, valued at approximately $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CTO John Rondoni sold 583 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the completion of the sale, the chief technology officer now directly owns 10,424 shares of the company’s stock, valued at $1,777,187.76. This represents a 5.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 26,225 shares of company stock worth $4,806,530 in the last 90 days. Company insiders own 4.10% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.